Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Only 8 Percent Of Older ICD-Eligible Heart Failure Patients Get An ICD, Study Finds

This article was originally published in The Gray Sheet

Executive Summary

Improved patient follow up and communications may be needed to get implantable defibrillators to more patients who need them, researchers say following a recent study finding fewer than 10 percent of eligible patients with low ejection fraction received an ICD within a year after a heart attack, even though ICD implants were associated with lower risk-adjusted two-year mortality in this group.

You may also be interested in...



Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005

The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input from 35 individuals, organizations, and companies during the initial public comment period. The agency did not specify any particular issues or deficiencies that it wants to address by updating its coverage policy, but CMS has not reconsidered the national coverage policy on ICDs since a major coverage expansion was implemented in 2005.

Ruing Registries: Emotions Run High Among EPs In Wake Of JAMA ICD Study

Discontent among electrophysiologists with the use of registries to track device trends and outcomes was palpable during the annual Heart Rhythm Society meeting earlier this month.

“Real-World” ICD Benefit Displayed In Boston Sci Latitude Network Data

New "real-world" data affirming the long-term benefits of implantable cardioverter defibrillators for heart failure patients highlighted the late-breaking trial sessions of the Heart Rhythm Society's 2009 conference in Boston last week

Related Content

Topics

UsernamePublicRestriction

Register

MT034002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel